Concepedia

Jacques Gaudreault

JG

22

Publications

4.1K

Citations

18

H-Index

1994

Active since

Affiliations

Roche (Switzerland)(Current)

Université de Montréal

Dynamic Research (United States)

University of North Carolina at Chapel Hill

Baylor University Medical Center

Jacques Gaudreault is an author at Roche (Switzerland) specializing in medicine, immunology, and pharmacotherapy.

Top concepts

Publications per year

1994–2023

22

Publications

22

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

David H. Johnson, Louis Fehrenbacher, William Novotny et al. · Journal of Clinical Oncology · 2004 · 1.9K citations · Full text

Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration

Jacques Gaudreault, David Fei, Jeriza Rusit et al. · Investigative Ophthalmology & Visual Science · 2005 · 501 citations

Phase Ib Trial of Intravenous Recombinant Humanized Monoclonal Antibody to Vascular Endothelial Growth Factor in Combination With Chemotherapy in Patients With Advanced Cancer: Pharmacologic and Long-Term Safety Data

Kim Margolin, Michael Gordon, Eric Holmgren et al. · Journal of Clinical Oncology · 2001 · 366 citations

Clinical pharmacokinetics of bevacizumab in patients with solid tumors

Jianfeng Lü, René Bruno, Steve Eppler et al. · Cancer Chemotherapy and Pharmacology · 2008 · 343 citations

, , +3

PHARMACOKINETICS AND RETINAL DISTRIBUTION OF RANIBIZUMAB, A HUMANIZED ANTIBODY FRAGMENT DIRECTED AGAINST VEGF-A, FOLLOWING INTRAVITREAL ADMINISTRATION IN RABBITS

Jacques Gaudreault, David Fei, Joseph C. Beyer et al. · Retina · 2007 · 185 citations

Rows per page

1–5 of 22